The significant drop in BioVie Inc's stock price is directly related to the announcement of a public offering at a price lower than its current trading price. This dilutes the value of existing shares and signals to the market that the stock might be overvalued at its previous price. The offering is substantial in size relative to the company's market cap, and the proceeds are intended for general corporate purposes, which may not provide immediate returns to investors.